WALD Waldencast plc

Nasdaq waldencast.com


$ 1.88 $ 0.02 (1.08 %)    

Monday, 13-Oct-2025 15:59:54 EDT
QQQ $ 595.78 $ 0.00 (0 %)
DIA $ 458.35 $ 0.00 (0 %)
SPY $ 657.89 $ 0.00 (0 %)
TLT $ 90.87 $ 0.00 (0 %)
GLD $ 380.88 $ 0.00 (0 %)
$ 1.88
$ 1.90
$ 1.78 x 230
$ 2.54 x 100
-- - --
$ 1.48 - $ 4.18
63,455
na
230.66M
$ 0.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-16-2022 03-31-2022 10-Q
2 03-31-2022 12-31-2021 10-K
3 11-18-2021 09-30-2021 10-Q
4 08-16-2021 06-30-2021 10-Q
5 07-16-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 waldencast-plans-to-launch-obagi-saypha-magiq-in-us-market-alongside-other-important-skin-care-innovations-in-2026

Waldencast plc (NASDAQ:WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Ad...

 waldencast-says-fda-approves-obagi-saypha-magiq-injectable-hyaluronic-acid-gel

Waldencast plc (NASDAQ:WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Ad...

 telsey-advisory-group-maintains-outperform-on-waldencast-lowers-price-target-to-3

Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and lowers the price target f...

 waldencast-provides-business-update-for-h1-2025-results-obagi-medical-delivers-h1-2025-double-digit-growth-in-its-core-strategic-channels-novaestiq-acquisition-doubles-the-brands-addressable-market-in-the-us-company-launches-an-exploration-of-strategic-alternatives-to-enhance-shareholder-value-company-postpones-h1-2025-earnings-release-and-conference-call-the-company-now-expects-net-revenue-growth-in-the-low-to-mid-single-digits

LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a globa...

 telsey-advisory-group-maintains-outperform-on-waldencast-maintains-4-price-target

Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and maintains $4 price target.

 waldencast-strengthens-obagi-medical-with-saypha-injectable-line-and-novaestiq-acquisition-expanding-into-2b-us-dermal-filler-market

Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolioNew produ...

 canaccord-genuity-maintains-buy-on-waldencast-lowers-price-target-to-5

Canaccord Genuity analyst Susan Anderson maintains Waldencast (NASDAQ:WALD) with a Buy and lowers the price target from $6 t...

 telsey-advisory-group-maintains-outperform-on-waldencast-lowers-price-target-to-4

Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and lowers the price target f...

 waldencast-q1-sales-6540m-down-from-6830m-yoy

Waldencast (NASDAQ:WALD) reported $65.40 million in sales this quarter. This is a 4.25 percent decrease over sales of $68.30 mi...

 waldencast-q1-preview-beauty-brand-glow-dims-on-soft-margins-flat-sales

WALD is reporting Q1 results on May 13, Telsey Advisory Group expects margin and earnings miss. Analyst Dana Telsey maintains o...

 telsey-advisory-group-maintains-outperform-on-waldencast-maintains-5-price-target

Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and maintains $5 price target.

 alliance-global-partners-initiates-coverage-on-waldencast-with-buy-rating-announces-price-target-of-5

Alliance Global Partners analyst Aaron Grey initiates coverage on Waldencast (NASDAQ:WALD) with a Buy rating and announces P...

 telsey-advisory-group-maintains-outperform-on-waldencast-lowers-price-target-to-5

Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and lowers the price target f...

 da-davidson-maintains-buy-on-waldencast-maintains-75-price-target

DA Davidson analyst Linda Bolton Weiser maintains Waldencast (NASDAQ:WALD) with a Buy and maintains $7.5 price target.

 telsey-advisory-group-maintains-outperform-on-waldencast-maintains-6-price-target

Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and maintains $6 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION